COMMUNIQUÉS West-GlobeNewswire

Catalyst Biosciences Announces Closing of Public Offering of Common Stock
22/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Cannabis Wheaton Income Corp. Announces Signing of Definitive Agreement With Streaming Partner CannTx Life Sciences Inc.
22/12/2017
VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is pleased to announce that further to its [...]
Biotricity Closes a Registered Direct Financing and Paves the Way for Bioflux Launch
22/12/2017
REDWOOD CITY, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
Cannabis Wheaton Income Corp. Announces Private Placement of Convertible Debenture Units and Conversion of Prior Convertible Debenture Units
22/12/2017
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]
American Health Council Appoints Tamra Ward MSN, ARNP, NP-C, CHFN, CCTC to its Nursing Board
22/12/2017
NEW YORK, Dec. 22, 2017 (GLOBE NEWSWIRE) -- The American Health Council Board of Nurses welcomes Tamra Ward MSN, ARNP, NP-C, CHFN, CCTC as an affiliate. With an extensive 38 years within the healthcare industry, [...]
BioCorRx Recovery Program Used in Lieu of Conviction in Ohio
22/12/2017
ANAHEIM, CA, Dec. 22, 2017 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that that [...]
Canada House Wellness Group’s Intended Uses of Funds from Recently Closed $8.6 Million Convertible Debenture Unit Financing
22/12/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]
Imaging3’s New CEO Provides end-of-year Company Update
22/12/2017
BURBANK, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG), a development stage company targeting disruptive technologies in the medical imaging industry, is finishing a transformative 2017 year and [...]
Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 36th Annual Healthcare Conference on January 10, 2018
22/12/2017
BOSTON, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced it will [...]
Alpha Pro Tech, Ltd. Announces Additional $2 Million Expansion to Share Repurchase Program
22/12/2017
NOGALES, Ariz., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American:APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]
GBT Appoints Wendy L. Yarno to Board of Directors
22/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced the appointment of Wendy L. Yarno to the company’s board of directors. Ms. Yarno has [...]
Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics
22/12/2017
Company to focus on advancing the clinical development of ELX-02, a disease-modifying therapy for genetic diseases caused by nonsense mutations WALTHAM, Mass., REHOVOT, Israel, and SAN DIEGO, Dec. 22, 2017 (GLOBE [...]
Tauriga Sciences, Inc. Extinguishes its Largest Remaining Balance Sheet Liability for One Time Cash Payment of $15,000 and One Time Issuance of 5,000,000 Restricted Shares; Liability Dated Back to the Years 2010/2011 and Totaled $177,883.71
22/12/2017
NEW YORK, NY, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]
Achaogen Announces New Employment Inducement Grants
22/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
Portola Pharmaceuticals to Webcast Corporate Update on January 9, 2018
22/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that it will host an investor event to discuss expected corporate and product milestones in [...]
Rhizen Pharmaceuticals S.A. receives FDA orphan-drug designation for Tenalisib (RP6530) for treatment of peripheral T-cell lymphoma (PTCL)
22/12/2017
La Chaux-de-Fonds, Switzerland, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the active moiety [...]
Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention of Pregnancy
22/12/2017
PRINCETON, N.J., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ: AGRX ), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued a complete response [...]
RedHill Biopharma Announces Initiation of Phase IIa Study with ABC294640 (YELIVA®) for Cholangiocarcinoma at Mayo Clinic and MD Anderson
22/12/2017
YELIVA ® , a proprietary, first-in-class SK2 inhibitor, was granted FDA Orphan Drug designation for the treatment of cholangiocarcinoma Cholangiocarcinoma (bile duct cancer) is a highly lethal malignancy for which there [...]
Avivagen Inc. Announces the Granting of Options
22/12/2017
OTTAWA, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V: VIV ) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]

Pages